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Peripheral blood mononuclear cells were isolated from an individual harboring a heterozygous c.859C → T
p.Q287* mutation in GFI1B, causing an autosomal dominant bleeding disorder, platelet type, 17 (BDPLT17).
PBMCs were differentiated to erythroblasts and reprogrammed by lentiviral delivery of a self-silencing hOKSM
polycistronic vector. Pluripotency of iPSC line was conﬁrmed by expression of associated markers and by
in vitro spontaneous differentiation towards the 3 germ layers. Normal karyotype conﬁrmed the genomic integ-
rity of iPSCs and the presence of disease causingmutationwas shown by Sanger sequencing. The generated iPSCs
can be used to study BDPLT17 pathophysiology and basic functions of GFI1B.
©2017 TheAuthors. Publishedby Elsevier B.V. This is an open access article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Resource table.
Unique stem cell line
identiﬁer
SANi005-A
Alternative name(s) of
stem cell line
BEL20 cl.8
Institution Sanquin, Amsterdam, The Netherlands
Contact information of
distributor
e.vandenakker@sanquin.nl
Type of cell line iPSC
Origin peripheral blood (mobilized) mononuclear cells-derived
EBL
Additional origin info Age:79
Sex: female
Cell source Erythroblast
Method of
reprogramming
Lentivirus
Genetic modiﬁcation NO
Type of modiﬁcation c.859C→ T p.Q287*
Associated disease BDPLT17
Gene/locus GFI1B
Method of modiﬁcation –
Name of transgene or
resistance
–
Inducible/constitutive
system
–
Date archived/stock
date
December 2015
Cell line
repository/bank
–
Ethical approval Informed consent was given in accordance with the
Declaration of Helsinki and Dutch national and Sanquin
internal ethic boards
Resource utility
We generated the iPSC line harboring the GFI1B p287*mutation. Be-
sides the conventional application of iPSC, this line can be useful to
study the role of GFI1B in various tissue and in particular during
megakaryopoiesis.
Resource details
Peripheral blood mononuclear cells (PBMC) were collected from a
female individual carrying a heterozygous c.859C→ T p.Q287*mutation
in growth factor independent 1B (GFI1B). The mutation has been de-
scribed to cause autosomal dominant gray platelet syndrome (OMIM
# 187900, BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17)
(Monteferrario et al., 2014). The premature stop codon at position 287
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Fig. 1. Characterization of SANi005-A iPSC line.
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results in a truncated proteinwith an incomplete zincﬁnger 5 andmiss-
ing the last zinc ﬁnger. The mutant transcript is not targeted by non-
sense mRNA mediated decay (Monteferrario et al., 2014). Patients
harboring this mutation show aberrant megakaryopoiesis and platelet
production/function (Monteferrario et al., 2014). Patient PBMCs were
isolated fromblood and cultured towards the erythroblast (EBL) lineage
as described before (Heideveld et al., 2015). Erythroblast (EBLs) was
transducedwith the self-inactivatingpRRL.PPT.SF.hOKSMco.GFP.preFRT
lentiviral vector. Reprogramming was performed on an irradiated
mouse embryonic ﬁbroblast (iMEF) feeder layer. The iPSC-like colonies
were individually picked 14–20 days post-transduction and SANi005-A
iPSC line was chosen for further examination based on morphology
criteria (Fig. 1A, scale bare 400 μm) (Tables 1 and 2).
No green ﬂuorescence was detected in the lentivirally
reprogrammed SANi005-A iPSC line which was similar to a non-GFP
episomal control iPSC line (SANi003-A), indicating silencing of the
reprogramming cassette (Fig. 1B). Pluripotency markers SOX2, OCT4,
SSEA4 and TRA-1-81 were expressed and iPSC colonies stained positive
for alkaline phosphatase (Fig. 1C, D scale bare 400 μm). The disease-
causing c.859C→ Tmutationwas conﬁrmed in SANi005-A by Sanger se-
quencing (Fig. 1E). The genomic integrity of SANI005-Awas assessed by
Giemsa-banding, indicating normal diploid 46, XX karyotype, without
any detectable abnormalities (Fig. 1F). In vitro spontaneous differentia-
tion revealed commitment to the three germline layers (shown in red)
by expression of ectodermal (βIII-TUBULIN), endodermal (GATA4) and
mesodermal (BRACHYURY) markers (Fig. 1G, blue Dapi, scale bare 40
μm). In conclusion, we have generated iPSC from hematopoietic cells
(erythroblasts) of a gray platelet-like BDPLT17 syndrome patient. The
generated iPSCs can be used to study BDPLT17 pathophysiology and
basic functions of GFI1B. Of note, besides this single fully characterized
line we have multiple (N15) additional not fully characterized lines
from this patient.
Materials and methods
Experimental procedures
All used chemicals were purchased from Sigma-Aldrich (Munich,
Germany) and all culture reagents from Thermo Fisher Scientiﬁc (Wal-
tham, Massachusetts, USA), unless otherwise speciﬁed.
Cell culture
All cells were cultured at 37 °C in humidiﬁed atmosphere containing
5% CO2. The iPSCswere cultured onMatrigel (BD Biosciences, Breda, The
Netherlands) in essential-8 medium (E8) following the manufacturer's
instructions.
Isolation of primary cell source and reprogramming of EBLs
PBMC-derived EBLs were cultured as described previously
(Monteferrario et al., 2014). Brieﬂy, PBMCswere isolated by ﬁcoll gradi-
ent and cultured in expansion medium supplemented with 100 ng/ml
SCF (R&D systems, Minneapolis, USA), 1 ng/ml IL-3 (R&D systems),
2 U/ml EPO (R&D systems), and 1 μM Dexamethasone (IL-3 was
added till day 2). 5 × 106 EBLs were transduced with
pRRL.PPT.SF.hOKSMco.idTomato.preFRT lentivirus (Warlich et al.,
2011; Voelkel et al., 2010). 3 days post-transduction the cellswere seed-
ed onto irradiated-MEF (GlobalStem, Gaitherburg, USA) in E8 medium
supplemented with 100 ng/ml SCF (R&D systems) and 2 mM valproic
acid (VPA) (1 × 106 EBLs/ml). From day 5 post-transduction E8
Table 1
Characterization and validation.
Classiﬁcation Test Result Data
Morphology Photography Normal Fig. 1A
Phenotype Immunocytochemisty Alkaline phosphatase positive Fig. 1D
Flow cytometry OCT/4: 94.4%
TRA-1-81: 53.5%
SSEA-4: 100%
SOX2: 96.6%
Fig. 1C
Genotype Karyotype (G-banding) and
resolution
46XX, Resolution 500 Fig. 1F
Identity Microsatellite PCR (mPCR) Not performed
STR analysis Performed on iPSC
Mutation analysis Sequencing c.859C→ T p.Q287* Fig. 1E
Southern Blot OR WGS Not performed
Microbiology and
virology
Mycoplasma Negative by MycoAlert Mycoplasma detection kit (Lonza #
LT07-118)
Not shown but available with
author
Differentiation potential Embryoid body formation Embryoid body formation to all three germ layers Fig. 1G
Donor screening HIV 1 + 2 Hepatitis B, Hepatitis C Negative not shown but available with author
Genotype additional info Blood group genotyping MLPA not shown but available with author
HLA tissue typing Unknown
Table 2
Reagents details.
Antibodies used for immunocytochemistry/ﬂow-cytometry
Antibody Dilution Company Cat # and RRID
Differentiation markers Mouse Neuronal Class III B-TUBULIN 1:2000 Covanc, # MMS-435P, AB_2313773
Rabbit anti-Brachyury 1:50 Santa Cruz, #sc-20,109, AB_2255702
Mouse anti-GATA4 1:50 Santa Cruz, #sc-25,310, AB_627667
Alkaline phosphates 1:500 Thermo Fisher Scientiﬁc, #A14353, No RRID
Secondary antibodies Donkey anti-Mouse IgG (H + L) secondary antibody 1:2000 Thermo Fisher Scientiﬁc, A-21202, AB_141607
Goat anti-Rabbit IgG (H+L) secondary antibody 1:2000 Thermo Fisher Scientiﬁc, A-11008, AB_143165
Pluripotency markers ﬂow cytometry TRA-1-81 1:100 Stem Cell Technologies, # 60065AZ.1, AB_1118559
OCT4 1:10 R&D Systems, IC1759A-100, AB_1152112
SOX2 1:10 R&D Systems, IC2018P-100, AB_357273
SSEA4 1:10 R&D Systems, FAB1435C, AB_1208043
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medium + VPA was added without SCF. From day 7 post-transduction
themediumwas changed to E8 and refreshed every second day hereaf-
ter. Day 14–20 post-transduction iPSCs-like colonies were individually
isolated and further expanded on Matrigel (BD Biosciences) coated
dishes (Table 1).
Karyotyping
Cells were treated with Demecolcine solution (10 μg/ml in HBSS),
and processed with standard methods. Giemsa-banded karyotyping
was performed and a minimum of 10 metaphases were analyzed. The
chromosomes were classiﬁed according to the International System
for Human Cytogenetic Nomenclature (ISCN, 2016).
In vitro spontaneous differentiation
iPSC cells were harvested using ReLeSR (Stem Cell Technologies,
Köln, Germany) according to manufacturer instructions and colony
clumps were transferred to an ultra-low attachment dish (Corning,
New York, USA) in E8 medium. On day 5 embryonic bodies (EB) were
plated on 0.1% gelatin coated coverslips in a 24 wells plate and medium
was changed to; 1% Pen/Strep, 20% FBS, 1% 100× MEM Non-essential
amino acid solution, 0.1 mM β-mercaptoethanol in DMEM. On day 14
EB were ﬁxed with 4% PFA before staining for all three germ layers
(Table 2).
Immunocytochemistry staining
The expression of speciﬁc pluripotency and germ layer markers was
analyzed using immunocytochemistry staining. The antibodies and ap-
plied dilutions are listed in Table 2. Cells were imaged using a LSM510
confocal with META detector (Carl Zeiss) and ﬁgures generated with
Zen black edition microscope software (Carl Zeiss).
Alkaline phosphatase staining
Alkaline phosphatase staining was performed by alkaline phospha-
tase live stain (AP) (Thermo Fisher Scientiﬁc). In short, the cultured
iPSCs were washed with DMEM/F12 prior to staining. E8 was added
on plates with AP live stain and incubated for 30 min, then washed
2× with DMEM/F12. Pictures were taken with EVOS-FL (Thermo Fisher
Scientiﬁc).
Flow cytometry
iPSC single cell suspensionsweremade using TrypLE Select, and cells
stained for pluripotency markers. Anti-TRA-1-81-APC (1:100; Stem cell
technologies), OCT4, SOX2, SSEA4 were performed according to manu-
facturer instructions (R&D Systems). Cells were washed and measured
on an LSR-II (BD Bioscience) and analyzed using Flowjo software
(Flowjo, Ashland, USA).
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